Nothing Special   »   [go: up one dir, main page]

NO20035265D0 - inhalation capsules - Google Patents

inhalation capsules

Info

Publication number
NO20035265D0
NO20035265D0 NO20035265A NO20035265A NO20035265D0 NO 20035265 D0 NO20035265 D0 NO 20035265D0 NO 20035265 A NO20035265 A NO 20035265A NO 20035265 A NO20035265 A NO 20035265A NO 20035265 D0 NO20035265 D0 NO 20035265D0
Authority
NO
Norway
Prior art keywords
inhalation capsules
inhalation
capsules
Prior art date
Application number
NO20035265A
Other languages
Norwegian (no)
Other versions
NO332857B3 (en
NO20035265L (en
NO332857B1 (en
Inventor
Dieter Hochrainer
Karoline Bechtold-Peters
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20035265(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20035265D0 publication Critical patent/NO20035265D0/en
Publication of NO20035265L publication Critical patent/NO20035265L/en
Publication of NO332857B1 publication Critical patent/NO332857B1/en
Publication of NO332857B3 publication Critical patent/NO332857B3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • A61M11/003Particle size control by passing the aerosol trough sieves or filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20035265A 2001-06-01 2003-11-27 Inhalation capsule and use of such NO332857B3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10126924A DE10126924A1 (en) 2001-06-01 2001-06-01 Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
PCT/EP2002/005600 WO2002098874A2 (en) 2001-06-01 2002-05-27 Inhalation capsules

Publications (4)

Publication Number Publication Date
NO20035265D0 true NO20035265D0 (en) 2003-11-27
NO20035265L NO20035265L (en) 2003-11-27
NO332857B1 NO332857B1 (en) 2013-01-21
NO332857B3 NO332857B3 (en) 2016-01-25

Family

ID=7687020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035265A NO332857B3 (en) 2001-06-01 2003-11-27 Inhalation capsule and use of such

Country Status (37)

Country Link
EP (2) EP1379220B1 (en)
JP (3) JP4447311B2 (en)
KR (2) KR100952321B1 (en)
CN (3) CN1512875A (en)
AR (2) AR034346A1 (en)
AT (1) ATE285752T1 (en)
AU (2) AU2002344354B2 (en)
BG (1) BG65655B1 (en)
BR (1) BR0209366A (en)
CA (1) CA2448425C (en)
CH (1) CH1379220H1 (en)
CO (1) CO5540379A2 (en)
CZ (1) CZ300284B6 (en)
DE (2) DE10126924A1 (en)
EA (1) EA005188B1 (en)
EC (2) ECSP034868A (en)
EE (1) EE05416B1 (en)
EG (1) EG24227A (en)
ES (1) ES2236590B5 (en)
HR (1) HRP20030993B1 (en)
HU (3) HU231082B1 (en)
IL (2) IL158917A0 (en)
ME (1) ME00301B (en)
MX (1) MXPA03010990A (en)
MY (1) MY126253A (en)
NO (1) NO332857B3 (en)
NZ (1) NZ530356A (en)
PE (1) PE20030071A1 (en)
PL (2) PL205714B1 (en)
PT (1) PT1379220E (en)
RS (1) RS50353B (en)
SI (1) SI1379220T1 (en)
SK (2) SK287379B6 (en)
TW (1) TWI327921B (en)
UA (1) UA75659C2 (en)
WO (1) WO2002098874A2 (en)
ZA (1) ZA200308340B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP40108A (en) 2000-10-12 2011-02-10 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
DE10212264A1 (en) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament
US20040025876A1 (en) * 2002-05-07 2004-02-12 Danforth Miller Capsules for dry powder inhalers and methods of making and using same
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (en) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg New tiotropium-containing powder formulation for inhalation
DE10258360A1 (en) * 2002-12-12 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Chamber for accommodation of disposable capsules for powder inhalers has an inner surface with protruding elements serving as distance pieces between the capsules
DE10352277A1 (en) * 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
SE0303269L (en) * 2003-12-03 2005-06-04 Microdrug Ag Medical product
SE0303570L (en) 2003-12-03 2005-06-04 Microdrug Ag Moisture-sensitive medical product
GB0503738D0 (en) * 2005-02-23 2005-03-30 Optinose As Powder delivery devices
US7694676B2 (en) 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
JP4825455B2 (en) * 2005-05-02 2011-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Powder inhaler
DE102006016901A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mouthpiece for an inhaler
DE102006016904A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
DE102007036411A1 (en) 2007-07-20 2009-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg powder inhaler
DE102007052871A1 (en) * 2007-11-02 2009-05-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Capsule for receiving pharmaceutical drug formulations
WO2009098083A1 (en) * 2008-02-08 2009-08-13 Boehringer Ingelheim International Gmbh Method and device for filling capsules
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
PL3578169T3 (en) 2009-02-26 2024-09-02 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
WO2010110760A1 (en) * 2009-03-27 2010-09-30 Mahmut Bilgic Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2011152804A2 (en) 2010-06-03 2011-12-08 Mahmut Bilgic Process for dry powder formulations
DE202011102694U1 (en) 2011-06-29 2011-12-19 Zisser Gmbh Inhaler for home users
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GEP201706672B (en) 2012-07-05 2017-05-25 Arven Ilac Sanayi Ve Ticaret As Dry powder inhaler compositions comprising long acting muscorinic antagonists
DE202013000774U1 (en) 2013-01-21 2013-04-15 Rhinofilt GmbH Miniaturized inhalation device for home use
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN108295042A (en) * 2018-03-05 2018-07-20 上海祺宇生物科技有限公司 A kind of plant hollow capsule and its capsule for sucking medicament
CN108451920A (en) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 A kind of suction mist formula capsule and preparation method thereof
CN114848605B (en) * 2022-03-25 2023-08-11 上海方予健康医药科技有限公司 Gelatin capsule for inhalation of powder fog agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
ES2159524T3 (en) * 1992-06-12 2001-10-16 Teijin Ltd PHARMACEUTICAL PREPARATION TO BE ADMINISTERED INSIDE THE RESPIRATORY ROADS.
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
DE19835346A1 (en) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Two-part capsule for pharmaceutical preparations for powder inhalers
JP2000143502A (en) * 1998-11-11 2000-05-23 Shionogi Qualicaps Kk Inhalant preparation
ATE382386T1 (en) * 1998-11-13 2008-01-15 Jagotec Ag MULTIDOSIS DRY POWDER INHALER WITH POWDER RESERVOIR
DE19921693A1 (en) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
EP1072258A1 (en) * 1999-07-28 2001-01-31 Greither, Peter Capsule for the release of bacteria, containing lyophilised bacteria and a method for the production thereof
EP1238661A1 (en) * 1999-10-12 2002-09-11 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability

Also Published As

Publication number Publication date
BG65655B1 (en) 2009-05-29
KR100921904B1 (en) 2009-10-16
RS50353B (en) 2009-11-10
KR20040007638A (en) 2004-01-24
PL364108A1 (en) 2004-12-13
AR084804A2 (en) 2013-06-26
WO2002098874A2 (en) 2002-12-12
ATE285752T1 (en) 2005-01-15
IL158917A0 (en) 2004-05-12
HUP0400666A2 (en) 2005-03-29
PT1379220E (en) 2005-03-31
AU2008203057C8 (en) 2017-04-06
IL158917A (en) 2008-11-03
CA2448425A1 (en) 2002-12-12
JP4787034B2 (en) 2011-10-05
EE200300595A (en) 2004-02-16
JP2008050364A (en) 2008-03-06
SI1379220T1 (en) 2005-04-30
MXPA03010990A (en) 2004-02-27
WO2002098874A3 (en) 2003-09-12
PE20030071A1 (en) 2003-03-04
PL205714B1 (en) 2010-05-31
JP2006143747A (en) 2006-06-08
JP4447311B2 (en) 2010-04-07
NZ530356A (en) 2005-05-27
EG24227A (en) 2008-11-10
CO5540379A2 (en) 2005-07-29
DE50201898D1 (en) 2005-02-03
TWI327921B (en) 2010-08-01
KR20090010140A (en) 2009-01-28
ES2236590B5 (en) 2018-03-05
HU231082B1 (en) 2020-06-29
ME00301B (en) 2011-05-10
HRP20030993B1 (en) 2011-10-31
NO332857B3 (en) 2016-01-25
PL387118A1 (en) 2004-12-13
HU230058B1 (en) 2015-06-29
CZ300284B6 (en) 2009-04-08
ECSP11004868A (en) 2011-02-28
EP1379220B1 (en) 2004-12-29
CN101697965A (en) 2010-04-28
JP2005500279A (en) 2005-01-06
HU230827B1 (en) 2018-07-30
YU93503A (en) 2006-05-25
EA200301275A1 (en) 2004-06-24
MY126253A (en) 2006-09-29
DE10126924A1 (en) 2002-12-05
AR034346A1 (en) 2004-02-18
AU2008203057A1 (en) 2008-07-31
AU2008203057C1 (en) 2017-05-18
EP1379220A2 (en) 2004-01-14
CN101829072A (en) 2010-09-15
BR0209366A (en) 2004-06-08
CN1512875A (en) 2004-07-14
SK287379B6 (en) 2010-08-09
HUP0400666A3 (en) 2009-06-29
PL203801B1 (en) 2009-11-30
EA005188B1 (en) 2004-12-30
BG108380A (en) 2004-11-30
CZ20033579A3 (en) 2004-05-12
NO20035265L (en) 2003-11-27
EE05416B1 (en) 2011-06-15
CH1379220H1 (en) 2018-10-31
ECSP034868A (en) 2004-03-23
NO332857B1 (en) 2013-01-21
SK287346B6 (en) 2010-07-07
KR100952321B1 (en) 2010-04-09
SK16202003A3 (en) 2004-05-04
CA2448425C (en) 2010-12-21
EP1508330A1 (en) 2005-02-23
AU2008203057B2 (en) 2011-12-08
AU2002344354B2 (en) 2008-08-07
HUP1500188A2 (en) 2005-03-29
ZA200308340B (en) 2004-05-21
MEP42508A (en) 2011-02-10
HRP20030993A2 (en) 2005-08-31
ES2236590T3 (en) 2005-07-16
UA75659C2 (en) 2006-05-15

Similar Documents

Publication Publication Date Title
DE50201898D1 (en) INHALATION CAPSULES
NO20022414D0 (en) Tiotropium-containing inhalation powder
NO20035122L (en) The inhalation device
EE200300416A (en) Pharmaceutical form
DE60204063D1 (en) blister
EE200200526A (en) Capsules
NO20021030D0 (en) Protection Capsule
DE10296152D2 (en) breathing device
NO20035315D0 (en) Pharmaceutical combinations
NO20033205D0 (en) Therapeutic kroman compounds
NO20024431D0 (en) capsules
DE50209245D1 (en) NEUROPROTEKTIVES MEDICAMENT
DE50203644D1 (en) abseiling
NO20041065L (en) Hydroksyfettsulfonsyre analogs
DE60225462D1 (en) WATER-SOLUBLE CAPSULES
FI20012242A0 (en) New pharmaceutical compounds
FI20011386A0 (en) Inhalation particles
DE60129610D1 (en) INHALER
UA5736S (en) RESPIRATOR
SE0100607L (en) Respirator
DK1330280T3 (en) drug inhaler
SE0102823D0 (en) New drug
SE0103116D0 (en) Pharmaceutical combination
NO20015559D0 (en) Kreklinggel ±
DK1267974T3 (en) inhaler

Legal Events

Date Code Title Description
LC4 Limitation of patent rights - b3 (par. 39b patent act)

Effective date: 20160125

PDP Decision of opposition (par. 25 patent act)

Free format text: PATENT NR. 332857 ER KJENT DELVIS UGYLDIG VED DOMSTOLSAVGJOERELSE.

MK1K Patent expired